Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
730.9%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 0.24Close
$ 0.19 - $ 0.44 52-Week Range
Ticker Information
Ticker
NWBOCompany Name
NORTHWEST BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
OTCNORTHWEST BIOTHERAPEUTICS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NWBO - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 8M | 730.9% | $ 1.09M |
| 3/31/2025 | $ 7.85M | 532.99% | $ 1.47M |
| 12/31/2024 | $ 7.77M | 562.01% | $ 1.38M |
| 9/30/2024 | $ 6.52M | 408.58% | $ 1.6M |
| 6/30/2024 | $ 6.11M | 371.49% | $ 1.65M |
| 3/31/2024 | $ 5.73M | 429.04% | $ 1.34M |
| 12/31/2023 | $ 5.24M | 271.27% | $ 1.93M |
| 9/30/2023 | $ 5.22M | 250.48% | $ 2.08M |
| 6/30/2023 | $ 5.06M | 268.68% | $ 1.88M |
| 3/31/2023 | $ 5.19M | 240.37% | $ 2.16M |
Key Performance Insights, Last 5 Years
- NORTHWEST BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 470.74%.
- Over the past 5 years, NORTHWEST BIOTHERAPEUTICS INC's average Int. Exp. % has been 477.76%.
- The median Int. Exp. % for NORTHWEST BIOTHERAPEUTICS INC during this period was 469.2%
- NORTHWEST BIOTHERAPEUTICS INC reached its highest Int. Exp. % over the past 5 years at 975.63%.
- The lowest Int. Exp. % recorded by NORTHWEST BIOTHERAPEUTICS INC in the same timeframe 240.37%
NORTHWEST BIOTHERAPEUTICS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for NORTHWEST BIOTHERAPEUTICS INC is calculated as follows: Int. Exp. [ $ 7.93M ] / Revenues [ $ 1.69M ]
(=) Int. Exp. % [ 470.74% ] NWBO - Interest Expense Margin, Last 5 years
240.37%
Minimum
Mar 31, 2023
975.63%
Maximum
Mar 31, 2021
477.76%
Average
469.2%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.48% |
| average | 1.62% |
| median | 0.79% |
| std | 2.19% |